Katalin Piroska Kiss

Co-occurrence of Myeloproliferative Neoplasms and Solid Tumors Is Attributed to a Synergism Between Cytoreductive Therapy and the Common <i>TERT</i> Polymorphism rs2736100

Tünde Krähling, Katalin Balassa, Katalin Piroska Kiss et al. · Cancer Epidemiology Biomarkers & Prevention · 2015 · 24 citations

The potential role of HLA-DRB1*11 in the development and outcome of haematopoietic stem cell transplantation-associated thrombotic microangiopathy

Katalin Balassa, Hajnalka Andrikovics, Péter Reményi et al. · Bone Marrow Transplantation · 2015 · 21 citations

Cell Therapy, Transplantation, Marrow Transplantation +13

<scp>HLA</scp> genetic diversity in Hungarians and Hungarian Gypsies: complementary differentiation patterns and demographic signals revealed by <scp>HLA</scp>‐A, ‐<scp>B</scp> and ‐<scp>DRB1</scp> in Central Europe

Dóra Inotai, Anikó Szilvási, Scott Benko et al. · Tissue Antigens · 2015 · 14 citations

Proteasome Subunit Beta Type 1 P11A Polymorphism Is a New Prognostic Marker in Multiple Myeloma

Gergely Varga, Gábor Mikala, Katalin Piroska Kiss et al. · Clinical Lymphoma Myeloma & Leukemia · 2017 · 12 citations

Hematological Malignancy, P11a Polymorphism, New Prognostic Marker +9